Calidi Biotherapeutics, Inc. (CLDI) stock
CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
$0.56−0.04 (-7.07%)
Close on Nov 17, 2026Market cap $1.45MP/E –Yield –
Calidi Biotherapeutics cash
Cash and short-term investments held at the end of each period.
Calidi Biotherapeutics's cash was $4.07M at Jun 30, 2026. For fiscal 2025 it was $5.60M, down 42.9% from the year before. The highest annual figure on record is $9.81M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.60M | -42.9% |
| FY2024 | Dec 31, 2024 | $9.81M | +352.7% |
| FY2023 | Dec 31, 2023 | $2.17M | +267.3% |
| FY2022 | Dec 31, 2022 | $590.00K | -73.6% |
| FY2021 | Dec 31, 2021 | $2.24M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.07M | -22.9% |
| Q1 FY2026 | Mar 31, 2026 | $6.63M | -37.2% |
| Q4 FY2025 | Dec 31, 2025 | $5.60M | -42.9% |
| Q3 FY2025 | Sep 30, 2025 | $10.38M | +446.9% |
| Q2 FY2025 | Jun 30, 2025 | $5.28M | +531.5% |
| Q1 FY2025 | Mar 31, 2025 | $10.56M | +824.0% |
| Q4 FY2024 | Dec 31, 2024 | $9.81M | +352.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.90M | -81.7% |
| Q2 FY2024 | Jun 30, 2024 | $836.00K | -63.4% |
| Q1 FY2024 | Mar 31, 2024 | $1.14M | +0.5% |
| Q4 FY2023 | Dec 31, 2023 | $2.17M | +267.3% |
| Q3 FY2023 | Sep 30, 2023 | $10.37M | +3355.0% |
| Q2 FY2023 | Jun 30, 2023 | $2.29M | +595.2% |
| Q1 FY2023 | Mar 31, 2023 | $1.14M | +90.3% |
| Q4 FY2022 | Dec 31, 2022 | $590.00K | -73.6% |
| Q3 FY2022 | Sep 30, 2022 | $300.00K | -74.9% |
| Q2 FY2022 | Jun 30, 2022 | $328.84K | +246.2% |
| Q1 FY2022 | Mar 31, 2022 | $597.52K | – |
| Q4 FY2021 | Dec 31, 2021 | $2.24M | – |
| Q3 FY2021 | Sep 30, 2021 | $1.20M | – |
| Q2 FY2021 | Jun 30, 2021 | $95.00K | – |
| Q1 FY2021 | Mar 23, 2021 | $0 | – |
See a number that looks wrong?